/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Arialys Therapeutics, Inc.

Arialys Therapeutics, Inc.

La Jolla, United States

Arialys Therapeutics is developing new precision medicines to specifically block the effect of pathogenic autoantibodies in the brain and meaningfully expand the treatment possibilities for neuropsychiatric disorders driven by autoimmune disease.

Healthcare & Biotech

Arialys Therapeutics, Inc., based in La Jolla, United States, has 2 investors on file, among them Avalon BioVentures and MPM BioImpact. Its site was last checked 6 Nov 2026: site answers.

arialysrx.com

SEC Form D filings

2 filings
$14.8M sold of $24.8M offered1 Jul 2025$14.3M sold of $55.0M offered2 Dec 2022

Filed by Arialys Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

2 investors on file
InvestorEvidenceType
Avalon BioVenturesPortfolio pageVenture capital
MPM BioImpactPortfolio pageVenture capital

More from Avalon BioVentures

7 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (75%), Fintech (13%), Crypto & Web3 (13%).

Jnana Therapeutics, Inc.Jnana Therapeutics develops small molecule medicines for various disea…Enlaza Therapeutics, Inc.Enlaza is developing first-in-class covalent protein therapeutics to t…Fortis TherapeuticsFortis Therapeutics is transforming outcomes for patients with cancer …JanuxJanux Therapeutics is developing precision-engineered immunotherapies …Valora TherapeuticsValora Therapeutics is developing next-generation multispecific antibo…

See Avalon BioVentures' full profile · Who invests alongside it

More from MPM BioImpact

19 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

AktisAktis Oncology develops targeted alpha-based radiopharmaceuticals for …Crossbow TherapeuticsCrossbow Therapeutics develops antibody therapeutics to treat cancer.Dyne TherapeuticsDyne Therapeutics develops nucleic acid therapies for rare diseases.Entrada TherapeuticsEntrada Therapeutics is working to treat devastating diseases with int…Frontier MedicinesFrontier Medicines is unlocking the proteome to develop a differentiat…

See MPM BioImpact's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Arialys Therapeutics, Inc. and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Avalon BioVentures adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/arialysrx.com/investors

# also
GET /v1/companies/arialysrx.com
GET /v1/companies/arialysrx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing